Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 229

1.

Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2.

Siebert N, Eger C, Seidel D, Jüttner M, Zumpe M, Wegner D, Kietz S, Ehlert K, Veal GJ, Siegmund W, Weiss M, Loibner H, Ladenstein R, Lode HN.

MAbs. 2016 Jan 19:1-13. [Epub ahead of print]

PMID:
26785755
2.

An mHealth system for toxicity monitoring of paediatric oncological patients using Near Field Communication technology.

Duregger K, Hayn D, Morak J, Ladenstein R, Schreier G.

Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015:6848-51. doi: 10.1109/EMBC.2015.7319966.

PMID:
26737866
3.

Management and Outcome of Ewing Sarcoma of the Head and Neck.

Grevener K, Haveman LM, Ranft A, van den Berg H, Jung S, Ladenstein R, Klco-Brosius S, Juergens H, Merks JH, Dirksen U.

Pediatr Blood Cancer. 2015 Dec 24. doi: 10.1002/pbc.25830. [Epub ahead of print]

PMID:
26702872
4.

Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence.

Taschner-Mandl S, Schwarz M, Blaha J, Kauer M, Kromp F, Frank N, Rifatbegovic F, Weiss T, Ladenstein R, Hohenegger M, Ambros IM, Ambros PF.

Oncotarget. 2015 Dec 9. doi: 10.18632/oncotarget.6527. [Epub ahead of print]

5.

G-CSF Is a Cancer Stem Cell-Specific Growth Factor-Letter.

Maris JM, Healy J, Park J, Ladenstein R, Pötschger U.

Cancer Res. 2015 Sep 15;75(18):3991. doi: 10.1158/0008-5472.CAN-15-1445. Epub 2015 Sep 3. No abstract available.

PMID:
26337906
6.

Ewing Sarcoma: Current Management and Future Approaches Through Collaboration.

Gaspar N, Hawkins DS, Dirksen U, Lewis IJ, Ferrari S, Le Deley MC, Kovar H, Grimer R, Whelan J, Claude L, Delattre O, Paulussen M, Picci P, Sundby Hall K, van den Berg H, Ladenstein R, Michon J, Hjorth L, Judson I, Luksch R, Bernstein ML, Marec-Bérard P, Brennan B, Craft AW, Womer RB, Juergens H, Oberlin O.

J Clin Oncol. 2015 Sep 20;33(27):3036-46. doi: 10.1200/JCO.2014.59.5256. Epub 2015 Aug 24. Review.

PMID:
26304893
7.

Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial.

van den Berg H, Paulussen M, Le Teuff G, Judson I, Gelderblom H, Dirksen U, Brennan B, Whelan J, Ladenstein RL, Marec-Berard P, Kruseova J, Hjorth L, Kühne T, Brichard B, Wheatley K, Craft A, Juergens H, Gaspar N, Le Deley MC; Euro-EWING99 Group.

Eur J Cancer. 2015 Nov;51(16):2453-64. doi: 10.1016/j.ejca.2015.06.123. Epub 2015 Aug 10.

PMID:
26271204
8.

Rigidity versus flexibility: the dilemma of understanding protein thermal stability.

Karshikoff A, Nilsson L, Ladenstein R.

FEBS J. 2015 Oct;282(20):3899-917. doi: 10.1111/febs.13343. Epub 2015 Jul 15. Review.

PMID:
26074325
9.

Standardized data sharing in a paediatric oncology research network--a proof-of-concept study.

Hochedlinger N, Nitzlnader M, Falgenhauer M, Welte S, Hayn D, Koumakis L, Potamias G, Tsiknakis M, Saraceno D, Rinaldi E, Ladenstein R, Schreier G.

Stud Health Technol Inform. 2015;212:27-34.

PMID:
26063254
10.

Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe.

Bölling T, Braun-Munzinger G, Burdach S, Calaminus G, Craft A, Delattre O, Deley MC, Dirksen U, Dockhorn-Dworniczak B, Dunst J, Engel S, Faldum A, Fröhlich B, Gadner H, Göbel U, Gosheger G, Hardes J, Hawkins DS, Hjorth L, Hoffmann C, Kovar H, Kruseova J, Ladenstein R, Leuschner I, Lewis IJ, Oberlin O, Paulussen M, Potratz J, Ranft A, Rössig C, Rübe C, Sauer R, Schober O, Schuck A, Timmermann B, Tirode F, van den Berg H, van Valen F, Vieth V, Willich N, Winkelmann W, Whelan J, Womer RB.

Klin Padiatr. 2015 May;227(3):108-15. doi: 10.1055/s-0035-1545263. Epub 2015 May 18.

PMID:
25985445
11.

Bone marrows from neuroblastoma patients: an excellent source for tumor genome analyses.

Abbasi MR, Rifatbegovic F, Brunner C, Ladenstein R, Ambros IM, Ambros PF.

Mol Oncol. 2015 Mar;9(3):545-54. doi: 10.1016/j.molonc.2014.10.010. Epub 2014 Oct 28.

12.

Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcoma.

Dantonello TM, Stark M, Timmermann B, Fuchs J, Selle B, Linderkamp C, Handgretinger R, Hagen R, Feuchtgruber S, Kube S, Kosztyla D, Kazanowska B, Ladenstein R, Niggli F, Ljungman G, Bielack SS, Klingebiel T, Koscielniak E; Cooperative Weichteilsarkom Studiengruppe [CWS].

Pediatr Blood Cancer. 2015 Jan;62(1):16-23. doi: 10.1002/pbc.25207. Epub 2014 Sep 27.

PMID:
25263634
13.

Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.

Le Deley MC, Paulussen M, Lewis I, Brennan B, Ranft A, Whelan J, Le Teuff G, Michon J, Ladenstein R, Marec-Bérard P, van den Berg H, Hjorth L, Wheatley K, Judson I, Juergens H, Craft A, Oberlin O, Dirksen U.

J Clin Oncol. 2014 Aug 10;32(23):2440-8. doi: 10.1200/JCO.2013.54.4833. Epub 2014 Jun 30.

14.

Challenges for children and adolescents with cancer in Europe: the SIOP-Europe agenda.

Vassal G, Fitzgerald E, Schrappe M, Arnold F, Kowalczyk J, Walker D, Hjorth L, Riccardi R, Kienesberger A, Jones KP, Valsecchi MG, Janic D, Hasle H, Kearns P, Petrarulo G, Florindi F, Essiaf S, Ladenstein R.

Pediatr Blood Cancer. 2014 Sep;61(9):1551-7. doi: 10.1002/pbc.25044. Epub 2014 Apr 7.

15.

Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN study.

Viprey VF, Gregory WM, Corrias MV, Tchirkov A, Swerts K, Vicha A, Dallorso S, Brock P, Luksch R, Valteau-Couanet D, Papadakis V, Laureys G, Pearson AD, Ladenstein R, Burchill SA.

J Clin Oncol. 2014 Apr 1;32(10):1074-83. doi: 10.1200/JCO.2013.53.3604. Epub 2014 Mar 3.

16.

Towards reducing inequalities: European Standards of Care for Children with Cancer.

Kowalczyk JR, Samardakiewicz M, Fitzgerald E, Essiaf S, Ladenstein R, Vassal G, Kienesberger A, Pritchard-Jones K.

Eur J Cancer. 2014 Feb;50(3):481-5. doi: 10.1016/j.ejca.2013.11.004. Epub 2013 Nov 30.

PMID:
24300454
17.

Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients: a SIOPEN Phase 1 study.

Ladenstein R, Weixler S, Baykan B, Bleeke M, Kunert R, Katinger D, Pribill I, Glander P, Bauer S, Pistoia V, Michon J, Garaventa A, Lode HN.

MAbs. 2013 Sep-Oct;5(5):801-9. doi: 10.4161/mabs.25215. Epub 2013 May 31.

18.

Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group.

Schultz RK, Baker KS, Boelens JJ, Bollard CM, Egeler RM, Cowan M, Ladenstein R, Lankester A, Locatelli F, Lawitschka A, Levine JE, Loh M, Nemecek E, Niemeyer C, Prasad VK, Rocha V, Shenoy S, Strahm B, Veys P, Wall D, Bader P, Grupp SA, Pulsipher MA, Peters C.

Biol Blood Marrow Transplant. 2013 Sep;19(9):1279-87. doi: 10.1016/j.bbmt.2013.07.006. Epub 2013 Jul 21.

19.

The lumazine synthase/riboflavin synthase complex: shapes and functions of a highly variable enzyme system.

Ladenstein R, Fischer M, Bacher A.

FEBS J. 2013 Jun;280(11):2537-63. doi: 10.1111/febs.12255. Epub 2013 Apr 24. Review.

20.

New policies to address the global burden of childhood cancers.

Sullivan R, Kowalczyk JR, Agarwal B, Ladenstein R, Fitzgerald E, Barr R, Steliarova-Foucher E, Magrath I, Howard SC, Kruger M, Valsecchi MG, Biondi A, Grundy P, Smith MA, Adamson P, Vassal G, Pritchard-Jones K.

Lancet Oncol. 2013 Mar;14(3):e125-35. doi: 10.1016/S1470-2045(13)70007-X. Epub 2013 Feb 20. Review.

PMID:
23434339
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk